Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.09 USD | +1.72% | -3.14% | -14.06% |
01/04 | Titan Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
26/01 | Titan Pharmaceuticals Regains Compliance With Nasdaq Listing Rule | MT |
Sales 2022 | 557K 46.44M | Sales 2023 | 184K 15.34M | Capitalization | 6.21M 518M |
---|---|---|---|---|---|
Net income 2022 | -10M -834M | Net income 2023 | -5M -417M | EV / Sales 2022 | 15.6 x |
Net cash position 2022 | 2.75M 229M | Net cash position 2023 | 6.2M 517M | EV / Sales 2023 | 0.11 x |
P/E ratio 2022 |
-1.03
x | P/E ratio 2023 |
-1.11
x | Employees | 4 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 54.53% |
1 day | +1.72% | ||
1 week | -3.14% | ||
Current month | -0.98% | ||
1 month | -3.93% | ||
3 months | +33.02% | ||
6 months | -15.72% | ||
Current year | -14.06% |
Members of the board | Title | Age | Since |
---|---|---|---|
Avraham Ben-Tzvi
BRD | Director/Board Member | 53 | 15/22/15 |
Gim Shen Seow
CEO | Chief Executive Officer | 42 | 12/23/12 |
Brynner Chiam
BRD | Director/Board Member | - | 12/23/12 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 7.09 | +1.72% | 10,649 |
24/24/24 | 6.97 | -0.57% | 2,582 |
23/24/23 | 7.01 | 0.00% | 1,329 |
22/24/22 | 7.01 | -4.23% | 604 |
19/24/19 | 7.32 | +3.09% | 2,979 |
Delayed Quote Nasdaq, April 27, 2024 at 02:00 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
-14.06% | 6.48M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- TTNP Stock